ProAssurance Co. (NYSE:PRA – Get Free Report) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 629,700 shares, a growth of 26.4% from the February 28th total of 498,300 shares. Based on an average trading volume of 593,200 shares, the short-interest ratio is currently 1.1 days. Approximately 1.3% of the company’s shares are sold short.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on ProAssurance in a research report on Tuesday. They issued a “hold” rating on the stock.
Get Our Latest Research Report on ProAssurance
Institutional Investors Weigh In On ProAssurance
ProAssurance Stock Performance
NYSE:PRA traded down $0.01 during midday trading on Tuesday, reaching $23.35. 123,347 shares of the company traded hands, compared to its average volume of 366,167. The company has a fifty day moving average price of $16.39 and a 200 day moving average price of $15.85. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of 28.13 and a beta of 0.21. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.28 and a quick ratio of 0.28. ProAssurance has a twelve month low of $10.76 and a twelve month high of $23.46.
ProAssurance (NYSE:PRA – Get Free Report) last issued its quarterly earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.19. The firm had revenue of $287.52 million during the quarter, compared to analyst estimates of $274.56 million. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. On average, analysts expect that ProAssurance will post 0.8 EPS for the current fiscal year.
ProAssurance Company Profile
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Recommended Stories
- Five stocks we like better than ProAssurance
- What is the Dow Jones Industrial Average (DJIA)?
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- What is a buyback in stocks? A comprehensive guide for investors
- Buffet Trims Equities, But Still Keeps Buying This Stock
- Consumer Staples Stocks, Explained
- Berkshire Hathaway Gains Defy Stock Market Slump
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.